Page 5 - Cingulate Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cingulate inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cingulate Inc Today - Breaking & Trending Today

Why Skechers Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Shares of Skechers U.S.A., Inc. (NYSE:SKX) shares fell during Friday’s session after the company reported mixed fourth-quarter financial re. ....

Tyra Biosciences , Andrew Bauch , Beazer Homes United States Inc , Shopify Inc , Gen Digital Inc , Apple Inc , Deckers Outdoor Corporation , Kopin Corporation , Bio Inc , Gaotu Techedu Inc , Revelation Biosciences Inc , Tyra Biosciences Inc , Holdings Limited , Atlassian Corporation , Intelligent Bio Solutions , Holdings Inc , Technology International Holdings Limited , Propertyguru Group Limited , Agriforce Growing Systems Ltd , Kiora Pharmaceuticals , Group Inc , Liberty Broadband Corporation , Addvantage Technologies Group , Cadrenal Therapeutics Inc , Clorox Company , Charter Communications Inc ,

Cingulate Announces Pricing of $7.5 Million Public Offering

Cingulate Announces Pricing of $7.5 Million Public Offering
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.

New York , United States , Kansas City , Matt Kreps , Thomas Dalton , Hc Wainwright Co , Exchange Commission , Cingulate Inc , Securities Exchange , Darrow Associates , Precision Timed Release , Looking Statements , Securities Act , Securities Exchange Act , Annual Report , Public Relations ,

Werth Family Investment Associates Converts Remaining $3.3M of Debt and Accrued Interest into ...

KANSAS CITY, Kan., Jan. 29, 2024 (GLOBE NEWSWIRE) Cingulate Inc. (NASDAQ: CING) (Cingulate), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to build ....

United States , Kansas City , Thomas Dalton , Matt Kreps , Peterj Werth , Darrow Associates , Securities Exchange , Exchange Commission , Platform Technology , Werth Family Investment Associates , Cingulate Therapeutics Llc Ctx , Cingulate Inc , Precision Timed Release , Cingulate Therapeutics , Note Conversion Agreement , Pre Funded Warrants , Securities Act , Hyperactivity Disorder , Erosion Barrier Layer , Looking Statements , Securities Exchange Act , Annual Report , Public Relations ,

Werth Family Investment Associates Converts Remaining $3.3M of Debt and Accrued Interest into Cingulate Equity at Premium to Market

Werth Family Investment Associates Converts Remaining $3.3M of Debt and Accrued Interest into Cingulate Equity at Premium to Market
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Kansas City , Thomas Daltonvice , Peterj Werth , Exchange Commission , Werth Family Investment Associates , Cingulate Inc , Securities Exchange , Cingulate Therapeutics Llc Ctx , Matt Krepsdarrow Associates , Precision Timed Release , Cingulate Therapeutics , Note Conversion Agreement , Pre Funded Warrants , Securities Act , Hyperactivity Disorder , Platform Technologycingulate , Erosion Barrier Layer , Looking Statements , Securities Exchange Act , Annual Report , Thomas Daltonvice President , Public Relations , Krepsdarrow Associates ,

ADHD field presents significant opportunity for drug developers

Stimulants, amphetamines, and methylphenidates are currently the first-line treatment for moderate to severe attention-deficit/hyperactivity disorder (ADHD) across the seven major global markets; France, Germany, Italy, Spain, the UK, the US, and Japan. ....

Lorraine Palmer , Globaldata Kols , Cingulate Inc , Neurocentria Incl Threonate Magnesium Salt , Axsome Therapeutics Inc , Neurocentria Inc , L Threonate Magnesium , Bio Developments , Markets Amp Regulations , Emerging Markets , Drug Delivery , Mental Health ,